Association of lipoprotein(a) with ischemia-reperfusion injury in patients with ST-elevation myocardial infarction.

IF 3.4 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Magdalena Holzknecht, Christina Tiller, Ivan Lechner, Fritz Oberhollenzer, Alex Kaser, Philipp Fischer, Anita Sandor, Can Gollmann-Tepeköylü, Agnes Mayr, Axel Bauer, Bernhard Metzler, Sebastian Johannes Reinstadler, Martin Reindl
{"title":"Association of lipoprotein(a) with ischemia-reperfusion injury in patients with ST-elevation myocardial infarction.","authors":"Magdalena Holzknecht, Christina Tiller, Ivan Lechner, Fritz Oberhollenzer, Alex Kaser, Philipp Fischer, Anita Sandor, Can Gollmann-Tepeköylü, Agnes Mayr, Axel Bauer, Bernhard Metzler, Sebastian Johannes Reinstadler, Martin Reindl","doi":"10.1007/s00392-026-03044-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hypercholesterolemia adversely affects ischemia-reperfusion injury in acute ST-elevation myocardial infarction (STEMI). Lipoprotein(a) (Lp(a)) is an independent cardiovascular risk factor beyond traditional lipid markers; however, its impact on ischemic myocardial injury remains unclear. We therefore investigated the association of Lp(a) with myocardial and microvascular damage assessed by multiparametric cardiovascular magnetic resonance (CMR), as well as clinical outcomes in STEMI patients.</p><p><strong>Methods and results: </strong>In this prospective MARINA-STEMI (NCT04113356) cohort study, 518 STEMI patients (median age 59 years, 19% female) treated with primary percutaneous coronary intervention (PCI) were included. Lp(a) and lipid parameters, including low-density lipoprotein (LDL) cholesterol, were measured at hospital admission. CMR was performed at a median of 4 days (interquartile range (IQR) 3-5) and 4 months (IQR 4-5) after PCI. The primary objective was to assess the association of Lp(a) with infarct size (IS) and severe microvascular injury, defined as intramyocardial hemorrhage (IMH) on baseline CMR. The clinical endpoint was major adverse cardiovascular events (MACE: all-cause death, re-infarction, or new congestive heart failure). Median Lp(a) and LDL cholesterol levels were 27 nmol/l (IQR 20-90) and 141 mg/dl (IQR 117-166), respectively. LDL cholesterol correlated with IS at baseline (ρ = 0.114, p = 0.010) and was higher in patients with IMH (145 vs. 140 mg/dl, p = 0.031). In contrast, Lp(a) showed no correlation with IS (ρ = 0.051, p = 0.246) and no association with IMH (25 vs. 28 nmol/l, p = 0.632). Elevated Lp(a) (≥ 105 nmol/l) was not associated with MACE (8.7% vs. 8.8%, p = 0.966).</p><p><strong>Conclusions: </strong>While LDL cholesterol was significantly associated with IS and IMH, Lp(a) was not related to ischemia-reperfusion injury patterns or clinical outcomes in patients with STEMI treated with primary PCI.</p>","PeriodicalId":10474,"journal":{"name":"Clinical Research in Cardiology","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research in Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00392-026-03044-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hypercholesterolemia adversely affects ischemia-reperfusion injury in acute ST-elevation myocardial infarction (STEMI). Lipoprotein(a) (Lp(a)) is an independent cardiovascular risk factor beyond traditional lipid markers; however, its impact on ischemic myocardial injury remains unclear. We therefore investigated the association of Lp(a) with myocardial and microvascular damage assessed by multiparametric cardiovascular magnetic resonance (CMR), as well as clinical outcomes in STEMI patients.

Methods and results: In this prospective MARINA-STEMI (NCT04113356) cohort study, 518 STEMI patients (median age 59 years, 19% female) treated with primary percutaneous coronary intervention (PCI) were included. Lp(a) and lipid parameters, including low-density lipoprotein (LDL) cholesterol, were measured at hospital admission. CMR was performed at a median of 4 days (interquartile range (IQR) 3-5) and 4 months (IQR 4-5) after PCI. The primary objective was to assess the association of Lp(a) with infarct size (IS) and severe microvascular injury, defined as intramyocardial hemorrhage (IMH) on baseline CMR. The clinical endpoint was major adverse cardiovascular events (MACE: all-cause death, re-infarction, or new congestive heart failure). Median Lp(a) and LDL cholesterol levels were 27 nmol/l (IQR 20-90) and 141 mg/dl (IQR 117-166), respectively. LDL cholesterol correlated with IS at baseline (ρ = 0.114, p = 0.010) and was higher in patients with IMH (145 vs. 140 mg/dl, p = 0.031). In contrast, Lp(a) showed no correlation with IS (ρ = 0.051, p = 0.246) and no association with IMH (25 vs. 28 nmol/l, p = 0.632). Elevated Lp(a) (≥ 105 nmol/l) was not associated with MACE (8.7% vs. 8.8%, p = 0.966).

Conclusions: While LDL cholesterol was significantly associated with IS and IMH, Lp(a) was not related to ischemia-reperfusion injury patterns or clinical outcomes in patients with STEMI treated with primary PCI.

st段抬高型心肌梗死患者脂蛋白(a)与缺血再灌注损伤的关系
背景:高胆固醇血症对急性st段抬高型心肌梗死(STEMI)的缺血再灌注损伤有不利影响。脂蛋白(a) (Lp(a))是一个独立的心血管危险因素,超越了传统的脂质标志物;然而,其对缺血性心肌损伤的影响尚不清楚。因此,我们研究了Lp(a)与心肌和微血管损伤的关系,通过多参数心血管磁共振(CMR)评估,以及STEMI患者的临床结果。方法和结果:在这项前瞻性marna -STEMI (NCT04113356)队列研究中,纳入了518例STEMI患者(中位年龄59岁,19%为女性),接受了初级经皮冠状动脉介入治疗(PCI)。入院时测量Lp(a)和脂质参数,包括低密度脂蛋白(LDL)胆固醇。CMR的中位时间为PCI术后4天(四分位间距(IQR) 3-5)和4个月(IQR 4-5)。主要目的是评估Lp(a)与梗死面积(IS)和严重微血管损伤(基线CMR定义为心肌内出血(IMH))的关系。临床终点是主要不良心血管事件(MACE:全因死亡、再梗死或新的充血性心力衰竭)。中位Lp(a)和LDL胆固醇水平分别为27 nmol/l (IQR 20-90)和141 mg/dl (IQR 117-166)。LDL胆固醇在基线时与IS相关(ρ = 0.114, p = 0.010),并且在IMH患者中更高(145 vs 140 mg/dl, p = 0.031)。Lp(a)与IS无关(ρ = 0.051, p = 0.246),与IMH无关(25 vs 28 nmol/l, p = 0.632)。Lp(a)升高(≥105 nmol/l)与MACE无关(8.7%比8.8%,p = 0.966)。结论:虽然低密度脂蛋白胆固醇与IS和IMH显著相关,但Lp(a)与STEMI患者接受初级PCI治疗的缺血再灌注损伤模式或临床结局无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Research in Cardiology
Clinical Research in Cardiology 医学-心血管系统
CiteScore
11.40
自引率
4.00%
发文量
140
审稿时长
4-8 weeks
期刊介绍: Clinical Research in Cardiology is an international journal for clinical cardiovascular research. It provides a forum for original and review articles as well as critical perspective articles. Articles are only accepted if they meet stringent scientific standards and have undergone peer review. The journal regularly receives articles from the field of clinical cardiology, angiology, as well as heart and vascular surgery. As the official journal of the German Cardiac Society, it gives a current and competent survey on the diagnosis and therapy of heart and vascular diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书